No­var­tis touts sev­en years of dura­bil­i­ty da­ta for Zol­gens­ma

3 years ago
R&D

'Band­ing to­geth­er': 50 fe­male biotech ex­ec­u­tives lay out plans for board di­ver­si­ty, new com­pa­nies and men­tor­ing ...

3 years ago
People

The ven­ture crew at Mubadala are up­ping their biotech cre­ation game, tak­ing care­ful aim at a new fron­tier in drug ...

3 years ago
Bioregnum
Discovery

Roche and Lil­ly team up to de­vel­op blood test to de­tect ear­ly signs of Alzheimer's

3 years ago
R&D

89bio’s PhII da­ta add to quick suc­ces­sion of NASH read­outs as field seeks turn­around

3 years ago
R&D

A $123M Flare will get Third Rock on­col­o­gy biotech in­to the clin­ic this year

3 years ago
Financing
Startups

Ex­clu­sive: Af­ter get­ting his drug back, Lan­dos founder as­sem­bles new start­up for the big PhI­II test

3 years ago
Startups

NIH re­jects an­oth­er at­tempt to 'march-in' on Astel­las' prostate can­cer drug over ex­ces­sive price

3 years ago
Pharma
Law

FDA warns Proc­ter & Gam­ble over NyQuil la­bel's in­gre­di­ent list­ings

3 years ago
FDA+
Manufacturing

FTC says patent bat­tle over Parkin­son's drug could have 'sig­nif­i­cant im­pli­ca­tion­s' for pa­tients

3 years ago
Pharma
Law

No­vo Nordisk re­mains un­der UK scruti­ny as MHRA con­ducts its own re­view in 'in­cred­i­bly rare' case

3 years ago
Pharma
Marketing

Growth hor­mone from No­vo Nordisk is in short­age over man­u­fac­tur­ing de­lays

3 years ago
Pharma
Manufacturing

PhRMA calls for more di­verse in­fra­struc­ture up­grades to US emer­gency tri­als frame­work

3 years ago
Pharma

Biden signs law re­quir­ing more de­clas­si­fi­ca­tions on Covid-19's ori­gins

3 years ago
Coronavirus

Im­mat­ics an­nounces mul­ti­ple pipeline changes with lat­est fi­nan­cial re­sults

3 years ago
R&D

Mar­ket­ingRx roundup: What could a US Tik­Tok ban mean for phar­ma? Pfiz­er, Lil­ly lead phar­ma March Mad­ness ad­ver­tis­ers

3 years ago
Pharma
Marketing

Chat­G­PT with phar­ma da­ta de­buts for med­ical meet­ings, be­gin­ning with AACR

3 years ago
AI
Pharma

Roche un­veils long-term da­ta from piv­otal spinal mus­cu­lar at­ro­phy tri­al

3 years ago
R&D
Pharma

Al­tim­mune’s shares halved af­ter in­ter­im look at PhII weight loss drug da­ta

3 years ago
R&D

Af­ter rais­ing $140M, SPAC will take biotech pub­lic with a frac­tion of planned funds

3 years ago
Financing

Who are the women break­ing bar­ri­ers in drug de­vel­op­ment? Nom­i­nate them for End­points' an­nu­al re­port

3 years ago
People

In­cyte touts mid-stage da­ta for new JAK in­hibitor but stops short of se­lect­ing PhI­II dose

3 years ago
R&D

Kite's head of re­search leaves for Flag­ship start­up Sonata

3 years ago
People
Startups

Con­tra­cep­tive mak­er Evofem lets com­mer­cial chief go, cuts CEO pay 40% to save cash

3 years ago
People
First page Previous page 358359360361362363364 Next page Last page
A service from the Financial Times